FDA Inspection
Shanghai Desano Chemical Pharmaceutical Co., Ltd.Shanghai Desano Chemical Pharmaceutical Co., Ltd. – FDA Inspection, Nov 17, 2023
Record Details
This FDA Inspection record concerns Shanghai Desano Chemical Pharmaceutical Co., Ltd., with an inspection on November 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 17, 2023
- Product Type
- Drugs
- People
- Colleen F. Hoyt (Issuing Officer)
- Nadeem I. Chaudhry (FDA Associated Person)
View Company Profile
ID · 82a9d127-9ec5-4be3-acbb-18cc9c5bff42
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1225414
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shanghai Desano Chemical Pharmaceutical Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 10, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 7, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shanghai Desano Chemical Pharmaceutical Co., Ltd.
- FDA Inspection 1009779 - 2017-03-10
- FDA Inspection 926398 - 2015-05-07
- FDA Inspection 790434 - 2012-06-07
- FDA Inspection 601220 - 2009-04-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.